Eiger BioPharmaceuticals

YTD

ALL

Why Robinhood?

You can watch EIGR and buy or sell other stocks, ETFs, and their options commission-free!

About EIGR

Eiger BioPharmaceuticals is a privately held biotechnology company that develops a novel antiviral therapy for Hepatitis Delta, a life-threatening, Orphan Disease with high unmet medical need and no approved therapy. The company is led by a management team experienced in the development and commercialization of rare disease therapeutics.

CEO

David Apelian, MD, PhD

CEODavid Apelian, MD, PhD

Employees

—

Employees—

Headquarters

Palo Alto, California

HeadquartersPalo Alto, California

Founded

2008

Founded2008

Employees

—

Employees—

EIGR Key Statistics

Market cap

12.59M

Market cap12.59M

Price-Earnings ratio

-0.17

Price-Earnings ratio-0.17

Dividend yield

—

Dividend yield—

Average volume

507.40

Average volume507.40

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$16.00

52 Week high$16.00

52 Week low

$1.10

52 Week low$1.10